{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:30:01Z","timestamp":1791041401922,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2018.00334","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T04:12:03Z","timestamp":1541477523000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders"],"prefix":"10.3389","volume":"6","author":[{"given":"Akihisa","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/333455a0","article-title":"Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease","volume":"333","author":"Kikuta","year":"1988","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Jones","year":"1988","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1349-7006.1989.tb02273.x","article-title":"Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection","volume":"80","author":"Ishihara","year":"1989","journal-title":"Jpn J Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1172\/JCI114168","article-title":"CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA","volume":"84","author":"Kawa-Ha","year":"1989","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1040-8428(02)00116-6","article-title":"Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disease","volume":"44","author":"Kawa","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","article-title":"How we treat chronic active Epstein-Barr virus infection","volume":"105","author":"Sawada","year":"2017","journal-title":"Int J Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(87)91980-5","article-title":"Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2","volume":"1","author":"Kawa-Ha","year":"1987","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1651-2227.1995.tb13547.x","article-title":"Chronic active Epstein-Barr virus infection in children in Japan","volume":"84","author":"Ishihara","year":"1995","journal-title":"Acta Paediatr"},{"key":"B10","first-page":"139","article-title":"Chronic active Epstein-Barr virus infection and lymphoproliferative diseases","volume":"45","author":"Kawa","year":"1998","journal-title":"Gann Monograph Cancer Res"},{"key":"B11","first-page":"1578","article-title":"Long-term prognosis of chronic active Epstein-Barr virus infection","volume":"110","author":"Kimura","year":"2006","journal-title":"J Jpn Pediatr Soc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(00)02488-0","article-title":"Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation","volume":"356","author":"Okamura","year":"2000","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/jid.2011.461","article-title":"Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected \u03b3\u03b4T cells","volume":"132","author":"Hirai","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bjd.13411","article-title":"Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites","volume":"172","author":"Miyake","year":"2015","journal-title":"Br J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1349-7006.1997.tb00305.x","article-title":"Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells","volume":"88","author":"Ishihara","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S","article-title":"Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites","volume":"54","author":"Ishihara","year":"1997","journal-title":"Am J Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood.V98.10.3173","article-title":"Mosquito allergy and Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease","volume":"98","author":"Kawa","year":"2001","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1532\/IJH97.05083","article-title":"Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-\/natural killer cell lymphoproliferative disease","volume":"82","author":"Koyama","year":"2005","journal-title":"Int J Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/bmt.2011.14","article-title":"Encouraging results of preserving ovarian function after allo-HSCT with RIC","volume":"47","author":"Shimizu","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbmt.2013.10.026","article-title":"Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases","volume":"20","author":"Sawada","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","article-title":"Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection: a retrospective analysis","volume":"93","author":"Arai","year":"2011","journal-title":"Int J Hematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","article-title":"A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder:adult patients with chronic active Epstein-Barr virus infection-like features","volume":"103","author":"Kawamoto","year":"2018","journal-title":"Haematologica"},{"key":"B24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/bmt.2016.3","article-title":"Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers","volume":"51","author":"Arai","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/pbc.22037","article-title":"Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin","volume":"53","author":"Beutel","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"B28","first-page":"183","article-title":"Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"89","author":"Imashuku","year":"2004","journal-title":"Haematologica"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pbc.24980","article-title":"Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group","volume":"61","author":"Kogawa","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajh.21247","article-title":"Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan","volume":"83","author":"Sato","year":"2008","journal-title":"Am J Hematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pbc.22310","article-title":"Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan","volume":"54","author":"Ohga","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/sj.bmt.1701620","article-title":"Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan","volume":"23","author":"Imashuku","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/pbc.24039","article-title":"Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"59","author":"Shiraishi","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B35","first-page":"165","article-title":"A case of EBV-associated hemophagocytic lymphohistioncytosis with profilferation of virus-infected B cells on relapse","volume":"29","author":"Kitano","year":"2017","journal-title":"J Pediatr Infect Dis Immunol."},{"key":"B36","first-page":"672","article-title":"Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis","volume":"16","author":"Qin","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cyto.2018.05.003","article-title":"The impact of cytokine gene polymorphisms on the outcome of HLA matched sibling hematopoietic stem cell transplantation","volume":"110","author":"Kamel","year":"2018","journal-title":"Cytokine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3324\/haematol.2017.174979","article-title":"HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis","volume":"102","author":"Huang","year":"2017","journal-title":"Haematologica"},{"key":"B39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2014.09.011","article-title":"Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells","volume":"41","author":"Hubbard-Lucey","year":"2014","journal-title":"Immunity"},{"key":"B40","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","article-title":"T-cell and NK-cell posttransplantation lymphoproliferative disorders","volume":"127","author":"Swerdlow","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol."},{"key":"B44","first-page":"1993","article-title":"Temporary effective treatment with L-asparaginase for a patient with refractory nasal NK\/T-cell lymphoma","volume":"32","author":"Sakamoto","year":"2005","journal-title":"Jpn J Cancer Chemother"},{"key":"B45","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/10428194.2012.720374","article-title":"Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure","volume":"54","author":"Takahashi","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell tumor study group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1349-7006.2012.02251.x","article-title":"Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Ishida","year":"2012","journal-title":"Cancer Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","article-title":"Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia","volume":"92","author":"Suzuki","year":"2010","journal-title":"Int J Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1158\/0008-5472.CAN-03-1562","article-title":"Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells","volume":"64","author":"Isobe","year":"2004","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","article-title":"Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"98","author":"Kasahara","year":"2001","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1128\/JVI.76.21.11139-11142.2002","article-title":"Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus","volume":"76","author":"Trempat","year":"2002","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/BF02983236","article-title":"Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease","volume":"78","author":"Kawa","year":"2003","journal-title":"Int J Hematol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-2559.2011.03976.x","article-title":"Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)\/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders","volume":"59","author":"Takahashi","year":"2011","journal-title":"Histopathology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1399-3046.2007.00873.x","article-title":"Two cases of chronic active Epstein-Barr virus infection in which EBV-specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation","volume":"12","author":"Miyamura","year":"2008","journal-title":"Pediatr Transplant"},{"key":"B55","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J Clin Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/bmt.2015.41","article-title":"Preferential depletion of host over donor T cells through in vivo decay of active rabbit-anti-thymocyte globulin levels during reduced intensity conditioning","volume":"50","author":"Sanacore","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.trim.2007.05.001","article-title":"The type of ATG matters \u2013 natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius","volume":"18","author":"Penack","year":"2007","journal-title":"Transpl Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood-2017-09-806737","article-title":"A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma","volume":"131","author":"Amengual","year":"2018","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","article-title":"How I treat T cell chronic active Epstein barr virus disease","volume":"131","author":"Bollard","year":"2018","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1182\/blood-2002-01-0039","article-title":"Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection","volume":"100","author":"Savoldo","year":"2002","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1182\/blood-2010-01-262311","article-title":"High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood","volume":"116","author":"Wang","year":"2010","journal-title":"Blood"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00334\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T04:12:06Z","timestamp":1541477526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00334\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":62,"alternative-id":["10.3389\/fped.2018.00334"],"URL":"https:\/\/doi.org\/10.3389\/fped.2018.00334","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"article-number":"334"}}